Gemcitabine Products(RenovoRx)

N/A

Report date: 2024/04/17 16:33:09

Base Information

Drug NameGemcitabine Products(RenovoRx)
Drug Alias NameN/A
ClassificationDrug and medical devices combination productsSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitorsRibonucleotide reductase inhibitors
TargetsDNARibonucleotide reductase
Therapy Area/IndicationsUterine NeoplasmsLung NeoplasmsPancreatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRenovorx Inc
China Registration ClassN/A

Develop Information

Active CompaniesRenovorx Inc
Inactive CompaniesN/A
Active IndicationsUterine NeoplasmsLung NeoplasmsPancreatic Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A